Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
By a prospective study the authors tried to assess the state of the fetoplacental unit in pathologic pregnancies. Depending on the given situation, the following analytical procedures were used:
oxytocin
test (OCT), placental beta-1-glycoprotein (
SP-1
), amnioscopy, and analysis of the liquor amnii ingredients (L/S relationship). By combining the above quoted procedures and taking into account obstetric factors (pelvic measures, cervical maturity), the assessment was made of the state of the fetus and the placenta, of the maturity grade and gestation age, and of the condition of the fetus for delivery by the planned induction of uterine contractions. Statistical analysis (the kappa 2 test) has shown that there is no difference in the results concerning the parameters observed, which speaks for good agreement between them. In the authors' opinion, none of the methods used is an absolutely valid test but their combination and dynamic observation along with a certain clinical experience, could lead to right conclusions about the state of the fetoplacental unit before induced labour.
...
PMID:[Assessment of the state of the fetoplacental unit before induction of labor and its outcome]. 31 23
Several genomic clones encoding carboxypeptidase-E (CPE) have been isolated and partially sequenced. Southern blot analysis indicates that a single copy of this gene is present in the rat genome. The entire gene spans approximately 50 kilobases and consists of nine exons, each of which contains protein-coding regions. Only one of the exon/intron junctions of the rat CPE gene is present in a comparable position within the genes for carboxypeptidase-A and -B, both of which are only 17-21% homologous to CPE at the amino acid level. Nuclease protection analysis shows that alternative splicing of exons 7, 8, and 9 does not occur, indicating that the heterogeneity of the C-terminal region of CPE is due to posttranslational processing. Primer extension and nuclease protection analyses have identified the 5' end of CPE mRNA to be 105 nucleotides up-stream from the ATG used for protein translation. The 5' flanking region does not contain TATA and/or CCAAT boxes in the near vicinity of the transcription initiation site. The 5' flanking region is GC rich, containing 70% GC residues over nucleotides -1 to -150 (relative to the transcription initiation site). Putative consensus sites for the enhancer elements
SP-1
, NF-1, Pan-1, and AP-2 are present in the region from -60 to -330. Since this report describes the first neuropeptide-processing enzyme gene to be partially sequenced, it is not possible to compare the sequence with those of other processing enzymes that show similar tissue-specific expression. However, comparison of the CPE sequence with 5' flanking regions of other neuroendocrine genes has revealed a short region (12-18 nucleotides) that is highly conserved among CPE, neuropeptide-Y,
oxytocin
, insulin, and tyrosine hydroxylase genes.
...
PMID:Structural characterization of the rat carboxypeptidase-E gene. 177 Sep 52